Psychocutaneous disease: Pharmacotherapy and psychotherapy

Helena Kuhn, Constance Mennella, Michelle Magid, Caroline Stamu-O'Brien, George Kroumpouzos

Research output: Contribution to journalReview article

10 Scopus citations

Abstract

Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.

Original languageEnglish (US)
Pages (from-to)795-808
Number of pages14
JournalJournal of the American Academy of Dermatology
Volume76
Issue number5
DOIs
Publication statusPublished - May 1 2017

    Fingerprint

Keywords

  • antidepressant
  • antipsychotic
  • cognitive-behavioral therapy
  • drug
  • management
  • pruritus
  • psychocutaneous
  • psychotherapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Kuhn, H., Mennella, C., Magid, M., Stamu-O'Brien, C., & Kroumpouzos, G. (2017). Psychocutaneous disease: Pharmacotherapy and psychotherapy. Journal of the American Academy of Dermatology, 76(5), 795-808. https://doi.org/10.1016/j.jaad.2016.11.021